Abstract

Genome sequence analysis of a lasalocid‐producing strain, Streptomyces sp. FXJ1.172, which was isolated from red soil, indicated its great untapped biosynthetic potential for novel secondary metabolites. A lasalocid‐null mutant Streptomyces sp. FXJ1.172ΔlodS, was then constructed to make way for the cryptic biosynthetic pathways. Consequently, a novel cyclodepsipeptide, named NC‐1, was activated and isolated from the lasalocid abolished mutant strain cultivated in glucose‐yeast extract‐malt extract (GYM) medium supplemented with ferric ion. The planar‐ and stereo‐structures of NC‐1 were elucidated based on detailed analyses of MS, NMR, and single‐crystal X‐ray diffraction data, revealing it as the first reported cyclodepsipeptide that is epoxidized at adjacent carbon atoms of the cinnamoyl fatty acid side chain. In assays of antimicrobial activity, NC‐1 exhibited moderate inhibition effects against Mycobacterium bovis bacille Calmette–Guérin (BCG).

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.